A
ACRO Biomedical Co Ltd
OTC:ACBM
ACRO Biomedical Co Ltd
OTC:ACBM
Price:
0.0222
USD
Market Closed
Market Cap:
$1.3m
Balance Sheet
Balance Sheet Decomposition
ACRO Biomedical Co Ltd
ACRO Biomedical Co Ltd
Balance Sheet Decomposition is not available for
ACRO Biomedical Co Ltd
ACRO Biomedical Co Ltd
Balance Sheet
ACRO Biomedical Co Ltd
ACRO Biomedical Co Ltd
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
1
+8%
|
1
-24%
|
1
-9%
|
0
-92%
|
0
-45%
|
0
-56%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+138%
|
0
-61%
|
0
+67%
|
0
+58%
|
0
+4%
|
0
+23%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
8
|
24
|
33
|
33
|
33
|
|
| Additional Paid In Capital |
1
|
1
|
32
|
32
|
32
|
32
|
32
|
|
| Other Equity |
0
|
0
|
24
|
8
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
1
-14%
|
1
-7%
|
0
-23%
|
0
N/A
|
0
-15%
|
0
-31%
|
|
| Total Liabilities & Equity |
1
N/A
|
1
+8%
|
1
-24%
|
1
-9%
|
0
-92%
|
0
-45%
|
0
-56%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
48
|
48
|
60
|
60
|
60
|
60
|
60
|
|
Switch to:
Switch to:
See Also
Discover More
